Annual Park City Update

Course Focus: Genitourinary Pathology and Hematopathology

Conference Registration Hotel Reservations

Overview

This timely course focuses on the recent advancements in genitourinary (GU) pathology and hematopathology to help general practice pathologists improve their diagnostic skills and appreciate their key roles in the new era of precision medicine. The presenters of the GU and hematopathology topics have been chosen from the distinguished anatomical and clinical pathology faculty from the University of Utah. We are excited to have two renowned keynote speakers: Dr. Jesse McKenney, a professor of Pathology, head of Surgical Pathology, and GU expert at the Cleveland Clinic Foundation, Cleveland, OH; and Dr. Olga Pozdnyakova, an associate professor of Pathology, director of Molecular Diagnostics at Brigham and Women’s Hospital, and director of the Molecular Genetic Pathology Fellowship Program at Harvard Medical School.

In the era of personalized medicine, the fields of pathology and medical oncology are rapidly evolving. This places an increasing demand on pathologists to keep abreast with the developments of the diagnostic process, including accurate assessment of morphology, ordering of the appropriate additional testing, and adjusting reporting practices. The primary objective of this course is to provide general practice pathologists with a comprehensive review of the most recent changes in the field. Those include the 2022 updates in the WHO classification of GU tumors, as well as upcoming changes in the classification of hematopoietic neoplasms (both WHO and ICC). Our faculty is excited to share their experience working with Huntsman Cancer Institute, a nationally recognized cancer treatment and research center. Discussion of challenging cases will allow our audience to strengthen their diagnostic skills, gain a better knowledge of currently available ancillary testing, and realize the therapeutic implications of diagnostic decisions.

Our GU presenters will explore some of the newly recognized renal tumors, suggest changes in reporting, review the clinical impact of changes in reporting of prostate cancer, and share examples of challenging cases with clinically relevant insights.

Regarding the highly specialized hematopathology field, the topics will focus on the role of a general practice pathologist in the diagnostic workup of common myeloid and lymphoid neoplasms, review of the recently emerging ancillary diagnostic modalities, high-yield updates in the classification of hematologic neoplasms, and a challenging distinction between neoplastic and nonneoplastic conditions. To enhance the experience, speakers with expertise in cytopathology, molecular pathology, and surgical urologic oncology will join our group of experts.

Please join us in the picturesque alpine resort town of Park City, Utah, for exciting updates from experts in the field. Our goal is to advance and diversify your pathology knowledge and skills as you learn more about the fields of BOTH genitourinary pathology and hematopathology. This meeting should enhance your ability to guide the workup of patients with genitourinary and hematologic malignancies and diseases and assist clinical teams in decision-making in the era of personalized medicine.


Premier Sponsors:
Blueprint Medicines logo Daiichi Sankyo, Inc logo NeoGenomics Laboratories logo Stemline Therapeutics logo

Sponsor:
APS Medical Billing logo


Keynote Speakers

Olga Pozdnyakova, MD, PhD

Olga Pozdnyakova, MD, PhD

Associate Pathologist, Brigham and Women's Hospital
Associate Medical Director of the Clinical Hematology Laboratory, Brigham and Women’s Hospital
Medical Director, Physicians Diagnostic Labs
Associate Professor, Pathology, Harvard Medical School

Dr. Olga Pozdnyakova is an associate professor of pathology at Harvard Medical School and a diagnostic hematopathologist at Brigham and Women’s Hospital/Dana Farber Cancer Institute. She serves as the medical director of the Hematology Laboratory at Brigham and Women’s Hospital and Physician Diagnostics Labs at the Brigham Health Harbor Medical Associates. Dr. Pozdnyakova is an author of over 90 peer-reviewed publications and reviews. She has authored chapters on the topic of myeloid neoplasm in several fundamental pathology textbooks, such as Diagnostic Histopathology of Tumors, Wintrobe’s Atlas of Clinical Hematology, Diagnosis of Blood and Bone Marrow Disorders, and Diagnostic Bone Marrow Hematopathology, and is a coauthor of the textbook Hematopathology: A Volume in the High Yield Pathology Series. She serves as a vice-chair of the College of American Pathologists Clinical Hematology and Microscopy Committee. Dr. Pozdnyakova has lectured on various topics at numerous national and international pathology meetings and educational courses.

Jesse K. McKenney, MD

Jesse K. McKenney, MD

Vice-Chair, Faculty Development, Department of Pathology, Cleveland Clinic
Section Head, Surgical Pathology, Cleveland Clinic

Dr. Jesse McKenney completed medical training at UT Southwestern Medical School, a pathology residency at Emory University, and a surgical pathology fellowship at Stanford University. He is currently vice-chair for faculty development in the Department of Pathology at the Cleveland Clinic, where he is a member of the gynecologic (GYN) and genitourinary (GU) subspecialty pathology sections, and has a busy general surgical pathology consultation service, specializing in esoteric and difficult-to-classify neoplasms. Dr. McKenney is coeditor of the 11th edition of Rosai and Ackerman’s Surgical Pathology. As the central reviewer for the Canary Prostate Active Surveillance (PASS) Study, his major academic interest is defining an optimal prognostic stratification system for use in active surveillance management.

Course Directors

Jonathon Mahlow, MD

Jonathon Mahlow, MD

Assistant Professor, University of Utah School of Medicine
Medical Director, Anatomic Pathology, ARUP Laboratories

Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation in Cleveland OH. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology, and the American Society for Clinical Pathology.

Anton Rets, MD, PhD

Anton Rets, MD, PhD

Assistant Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Anton Rets is a medical director of hematopathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Rets received a doctorate degree in pathology from Perm State Medical Academy/St. Petersburg Academy of Postgraduate Medical Education. He then earned his medical degree and completed a pathology residency at Perm State Medical Academy. He also completed an anatomic and clinical pathology residency at the State University of New York Downstate Medical Center before completing a hematopathology fellowship at the University of Utah School of Medicine. Dr. Rets is board certified in anatomic and clinical pathology and hematopathology. He has received several awards, including the Outstanding Teaching award in clinical pathology, the Excellence in Leadership award, and the Outstanding Academic Performance Federal award. His research interests include red blood cell disorders, nonneoplastic hematology, and digital microscopy.

Faculty

Daniel Albertson, MD

Daniel Albertson, MD

Associate Professor, University of Utah School of Medicine
Division Chief, Anatomic Pathology and Molecular Oncology, ARUP Laboratories

Dr. Albertson is an associate professor of pathology at the University of Utah School of Medicine and currently serves as the Division Chief for Anatomic Pathology and Molecular Oncology. He previously served as the Section Head for Surgical Pathology as well as the head of Genitourinary Pathology. He received his MD from the University of Nebraska and completed his residency in anatomic and clinical pathology at Creighton University, followed by a surgical pathology fellowship at the University of Utah. While at Creighton, Dr. Albertson served as the chief resident for two years and received the Hal Lankford Pathology Resident Award. He is a member of United States and Canadian Academy of Pathology and the College of American Pathologists. Dr. Albertson’s special research interests include oncologic genitourinary, gynecologic, and solid tumor pathology.

Marc Barry, MD

Marc Barry, MD

Associate Professor, University of Utah School of Medicine
Medical Director, Genitourinary Pathology, ARUP Laboratories

Dr. Marc Barry is a medical director of anatomic pathology at ARUP Laboratories and an associate professor at the University of Utah School of Medicine. He received his medical degree from University College Dublin before completing an anatomic pathology residency at the Brigham and Women’s Hospital. Following his residency, Dr. Barry completed a post-doctoral research fellowship at the Massachusetts Institute of Technology. He then continued on to finish both a medical renal pathology fellowship and a urologic pathology fellowship at Brigham and Women’s Hospital. Dr. Barry is board certified in anatomic pathology and is affiliated with several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists. He is also the recipient of multiple awards, including the Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, the Research Scholarship Award from the College of American Pathology Foundation, and for Excellence in Urologic Resident Education from the University of New Mexico. Dr. Barry’s research interests include clinicopathologic questions in medical renal and urologic pathology as well as epidemiologic and translation aspects of urologic neoplasia.

Peng Li, MD, PhD

Peng Li, MD, PhD

Assistant Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Peng Li is a medical director of hematopathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Li received her doctorate degree in molecular pharmacology and structural biology from Thomas Jefferson University and her medical degree from Peking University Health Science Center. She then completed an anatomic and clinical pathology residency at the University of Utah School of Medicine. Following residency, Dr. Li completed a hematopathology fellowship at Stanford University and a molecular genetic pathology fellowship at Baylor College of Medicine. Dr. Li is board certified in anatomic and clinical pathology, molecular genetic pathology, and hematopathology. Her research interests include genetic aspects of myeloid and lymphoid malignancies and myeloid neoplasms with germline predisposition.

Madhu P. Menon, MD, PhD

Madhu P. Menon, MD, PhD

Associate Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Madhu P. Menon, MD, is a medical director of hematopathology and an associate director professor at the University of Utah School of Medicine. Dr. Menon obtained his medical degree from Baroda Medical College, Maharaja Sayajirao University, and a doctorate degree in molecular medicine from the Huck Institute of Life Sciences, Pennsylvania State University. He then completed his anatomic and clinical pathology residency at the University of Massachusetts Medical School and hematopathology fellowships from the National Institutes of Health/National Cancer Institute, George Washington University Hospital, and Johns Hopkins University Hospital as well as a postdoctoral fellowship at the Maine Medical Center Research Institute. Dr. Menon is board certified in hematopathology, anatomic and clinical pathology. He also has a Lean Silver Certification, LEAN training for Healthcare Leaders. His research interests include diagnostic and prognostic markers in lymphomas, molecular characterization of lymphomas, and biomarkers for early detection of progression and transformation of low-grade lymphomas.

David P. Ng, MD

David P. Ng, MD

Assistant Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. David P. Ng is a medical director of hematopathology at ARUP Laboratories and an assistant professor of pathology at the University of Utah. Dr. Ng received his medical degree from the University of Illinois at Chicago College of Medicine. He then completed an anatomic and clinical pathology residency at Dartmouth-Hitchcock Medical Center and a hematopathology fellowship at the University of Washington. Dr. Ng is board certified in anatomic and clinical pathology and hematology. He is the recipient of the Janis Giorgi Young Investigator award and the John H. Rippey Grant for Laboratory Quality Assurance. His research interests include minimal residual disease testing, clinical flow cytometry, and deep learning applications in flow cytometry.

Robert S. Ohgami, MD, PhD

Robert S. Ohgami, MD, PhD

Professor, University of Utah School of Medicine
Chief Medical Director, Research and Development in Integrated Oncology and Genetics, ARUP Laboratories

Dr. Robert Ohgami is a chief medical director for Research and Development in integrated oncology and genetics at ARUP Laboratories, and a professor at the University of Utah School of Medicine. He received his medical degree at Harvard Medical School and his doctorate degree at Harvard University. Dr. Ohgami completed his residency in anatomic pathology and a fellowship in hematopathology from Stanford University. He is certified by the American Board of Pathology in anatomic pathology and hematology. Dr. Ohgami received the Berard-Dorfman Founders Award from the Society for Hematopathology. His research interests include translational molecular pathology, clinical laboratory testing, and hematopathology.

Evan Raps, MD

Evan Raps, MD

Assistant Professor, University of Utah School of Medicine
Pathologist, ARUP Laboratories

Dr. Evan Raps is a medical director at ARUP Laboratories, and an assistant professor at the University of Utah School of Medicine. Dr. Raps completed his medical degree at the University of Nevada Medical School. He then completed his residency in anatomic and clinical pathology at the University of Utah School of Medicine as well as a residency in anatomic pathology at the University of Utah School of Medicine/ARUP Laboratories and a cytopathology fellowship at the University of Utah School of Medicine. Dr. Raps is certified by the American Board of Pathology. He specializes in cytopathology as well as head and neck pathology. His research interests include digital pathology.

Alejandro Sanchez, MD

Alejandro Sanchez, MD

Assistant Professor, University of Utah School of Medicine
Investigator, Huntsman Cancer Institute

Dr. Alejandro Sanchez is an assistant professor of urology at the University of Utah School of Medicine and a Huntsman Cancer Institute investigator. Dr. Sanchez specializes in the surgical care of patients with urologic cancers using open, laparoscopic, robotic, and endoscopic techniques. His practice at the Huntsman Cancer Institute primarily focuses on the multidisciplinary treatment of patients with prostate, bladder, kidney, testicular, adrenal, urethral, and penile cancers.

Dr. Sanchez received his undergraduate degree from the University of Florida where he graduated summa cum laude in biochemistry. He earned his medical degree from Harvard Medical School and completed his urologic surgery training at Massachusetts General Hospital. Dr. Sanchez then completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center where he received a Young Investigator Award from the American Society of Urologic Oncology to evaluate the mechanisms underlying the association of sarcopenia (low skeletal muscle mass) and poor oncologic outcomes in patients with clear cell renal cell carcinoma. During his fellowship, Dr. Sanchez also received the Chairman’s Award for Excellence in Basic Science.

Dr. Sanchez’s research efforts are primarily focused on clinical trial development and translational research.

Anna M. Shestakova, MD, PhD

Anna M. Shestakova, MD, PhD

Assistant Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Anna Shestakova is a medical director of Hematopathology and Molecular Genetic Pathology at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. She received a medical degree from Bogomolets National Medical University and a doctorate degree from the University of Utah. She completed a residency in anatomical and clinical pathology at the University of California, Irvine School of Medicine, and she completed fellowships in hematopathology at the University of Michigan and molecular genetic pathology at the University of Utah School of Medicine. Dr. Shestakova is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. She is also a member of the Educational Commission for Foreign Medical Graduates. Her research interests include small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and the role of TP53 in the clonal evolution of lymphoid and myeloid neoplasms.

Deepika Sirohi, MD

Deepika Sirohi, MD

Associate Professor, University of Utah School of Medicine
Medical Director, Solid FISH Pathology, ARUP Laboratories

Dr. Deepika Sirohi is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Sirohi received her medical degree from the Armed Forces Medical College and then completed a residency in anatomic and clinical pathology at the University of Texas Health Science Center. She completed a genitourinary pathology fellowship at the Cedar-Sinai Medical Center and a molecular genetic pathology fellowship at the University of California. Dr. Sirohi is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic alteration in urologic malignancies, viral oncogenesis, and applications of next generation sequencing to solid tumors.

Margaret Williams, MD

Margaret Williams, MD

Assistant Professor, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Margaret Williams is a medical director of Hematopathology at ARUP Laboratories, and an assistant professor (clinical) for the University of Utah School of Medicine. She received her medical degree from the University of North Carolina School of Medicine. She completed a residency in anatomic and clinical pathology from the University of Utah School of Medicine and a fellowship in hematopathology and molecular genetic pathology from the University of Utah School of Medicine. Dr. Williams is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. Her research interests include molecular findings in hematologic malignancies and quality improvement.


COVID-19 Adherence Policy:

The University of Utah Department of Pathology and ARUP Laboratories are committed to providing a safe and healthy atmosphere for our conference attendees. The Park City AP Update planning committee will continue to work closely with the Lodges at Deer Valley to follow all current recommendations from local, state, and federal health authorities to adhere to safety measures as needed.

The University of Utah Department of Pathology and ARUP Laboratories reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event of a cancellation or postponement of this conference, registration fees will be refunded in full; however, the University of Utah Department of Pathology and/or ARUP Laboratories is not responsible for any other related costs, charges, or expenses incurred by registrants of this conference.

Contact

For more information about this conference, or potential vendor sponsorship opportunities, please contact Steven Staroscik at steven.staroscik@aruplab.com.